STOCK TITAN

Sensei Biotherapeutics, Inc. (SNSE) Net Income by Year

SNSE

Sensei Biotherapeutics, Inc. reported a net loss of $21.1M in fiscal year 2025. This represents an increase of 30.1% from the prior fiscal year. The table below carries 6 fiscal years, from 2020 to 2025, and the quarters Sensei Biotherapeutics, Inc. has filed alongside them.

FY2025 annual
Net Income -$21.1M
YoY +30.1%
Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

SNSE Net Income by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY23FY22FY21FY20
Net Income-$21.1M+30.1%-$30.2M+11.6%-$34.1M+29.8%-$48.6M-32.1%-$36.8M-83.1%-$20.1M

SNSE Net Income by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'23Q3'23Q2'23
Net Income-$170.2M-2380.1%N/A-$4.6M+37.0%-$4.9M+30.9%-$6.9M+14.1%N/A-$7.3M-1.8%-$7.1M+23.9%-$8.0M+21.5%N/A-$7.1M+46.9%-$9.4M+10.9%

What net income means

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line.

More Sensei Biotherapeutics, Inc. financials

Frequently Asked Questions

What was Sensei Biotherapeutics, Inc.'s net income in fiscal year 2025?

Sensei Biotherapeutics, Inc. reported a net loss of $21.1M in fiscal year 2025.

How fast is Sensei Biotherapeutics, Inc.'s net income growing?

Sensei Biotherapeutics, Inc. (SNSE) net income rose by 30.1% year over year, from -$30.2M to -$21.1M in fiscal year 2025.

How has Sensei Biotherapeutics, Inc.'s net income changed over the years?

Across the 6 fiscal years this page covers, Sensei Biotherapeutics, Inc. (SNSE) net income went from -$20.1M in fiscal year 2020 to -$21.1M in fiscal year 2025.

Sensei Biotherapeutics, Inc. (SNSE) reported -$170.2M in net income in Q1 2026. This represents a decrease of 2380.1% from the same quarter a year earlier.

Net income is what is left of revenue once every cost is counted, interest and tax included, so a company can grow its sales and still report a loss on this line. This page lists what Sensei Biotherapeutics, Inc. (SNSE) reported on that line in every period on record.